Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk
暂无分享,去创建一个
Mads Thomassen | Julian Peto | Peter A. Fasching | Kyriaki Michailidou | Amanda B. Spurdle | Graham G. Giles | Alfons Meindl | Thilo Dörk | Christopher A. Haiman | Barbara Burwinkel | Maartje J. Hooning | Arto Mannermaa | Paolo Peterlongo | Douglas F. Easton | Antonis C. Antoniou | Lesley McGuffog | Daniel Barrowdale | Susan M. Domchek | Ana Osorio | Sue Healey | Alison M. Dunning | Stig E. Bojesen | Hermann Brenner | Christian F. Singer | Ignacio Blanco | Kenneth Offit | Joe Dennis | Per Hall | Heli Nevanlinna | Angela Cox | Robert Winqvist | Georgia Chenevix-Trench | Javier Benitez | Pascal Guénel | Kristiina Aittomäki | Nick Orr | Monica Barile | Qin Wang | Jacques Simard | Paolo Radice | Anna Jakubowska | Peter Devillee | Montserrat García-Closas | Jenny Chang-Claude | Diether Lambrechts | David E. Goldgar | Melissa C. Southey | Daniel Vincent | David Altshuler | Marjanka K. Schmidt | Roger L. Milne | Daniel C. Tessier | Susan Peock | Fergus J. Couch | Rita K. Schmutzler | Mark Robson | Chris Jacobs | Marc Tischkowitz | Dominique Stoppa-Lyonnet | Penny Soucy | Mia M. Gaudet | Gad Rennert | Paul D. P. Pharoah | Susan L. Neuhausen | Julian Adlard | Anna González-Neira | Joseph Vijai | Robert J. Klein | Maurizio Genuardi | Jeffrey N. Weitzel | Debra Frost | Conxi Lazaro | Guillermo Pita | Magdalena Lochmann | Sara Margolin | Irene L. Andrulis | Ans M. W. van den Ouweland | M. Rosario Alonso | Francois Bacot | Siranoush Manoukian | Barbara Wappenschmidt | Ed Dicks | Steve Ellis | Radka Platte | Elena Fineberg | Katherine L. Nathanson | Francesca Damiola | Norbert Arnold | Elinor J. Sawyer | D. Gareth Evans | Laure Barjhoux | Eitan Friedman | Andrew Lee | Sylvie Mazoyer | Georg Pfeiler | Christian Sutter | Sohela Shah | Muriel Belotti | Tomas Kirchhoff | Marion Piedmonte | Trinidad Caldes | Xianshu Wang | Vernon S. Pankratz | Sandra Fert Ferrer | Phuong L. Mai | Mark H. Greene | Michel Longy | Nils Schoof | Uffe Birk Jensen | Karoline B. Kuchenbaecker | Olga M. Sinilnikova | Ronald C. Eldridge | Frans B. L. Hogervorst | Thomas v. O. Hansen | Judith Garber | Emma D'Andrea | Elizabeth J. van Rensburg | Adalgeir Arason | Annemarie H. van der Hout | Carolien M. Kets | Cora M. Aalfs | Juul T. Wijnen | Margreet G. E. M. Ausems | Mary E. Porteous | Lisa Golmard | Manjeet K. Humphreys
[1] Francesmary Modugno,et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. , 2007, Cancer research.
[2] S Gaubatz,et al. Transcriptional activation by Myc is under negative control by the transcription factor AP‐2. , 1995, The EMBO journal.
[3] F. Couch,et al. Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers , 2008 .
[4] Bin Zhang,et al. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. , 2011, Cancer research.
[5] Elaine A. Ostrander,et al. Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium , 2008, Cancer Epidemiology Biomarkers & Prevention.
[6] Christiana Kartsonaki,et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.
[7] W. G. Hill,et al. Deviations from Hardy-Weinberg proportions: sampling variances and use in estimation of inbreeding coefficients. , 1984, Genetics.
[8] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[9] Mads Thomassen,et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 , 2011, Breast Cancer Research.
[10] W. Chung,et al. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.
[11] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[12] D. Easton,et al. Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations , 2012, Genetic epidemiology.
[13] Paul D.P. Pharoah,et al. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. , 2007, Journal of the National Cancer Institute.
[14] K. Lange,et al. Programs for pedigree analysis: Mendel, Fisher, and dGene , 1988, Genetic epidemiology.
[15] Mads Thomassen,et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. , 2009, Human molecular genetics.
[16] Christiana Kartsonaki,et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. , 2011, Human molecular genetics.
[17] P. Visscher,et al. A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.
[18] References , 1971 .
[19] Mads Thomassen,et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. , 2010, Cancer research.
[20] M. Daly,et al. Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer , 2010, PLoS genetics.
[21] H A Risch,et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.
[22] F. Couch,et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.
[23] Dieter Niederacher,et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.
[24] Peter Kraft,et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk , 2011, Nature Genetics.
[25] R. Weigel,et al. Tumor Suppressor Activity of AP2α Mediated through a Direct Interaction with p53* , 2002, The Journal of Biological Chemistry.
[26] W. Chung,et al. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[27] B. Kreike,et al. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling. , 2011, Cancer research.
[28] Mads Thomassen,et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers , 2012, Breast Cancer Research.
[29] R. Buettner,et al. Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer , 2005, Modern Pathology.
[30] Yurii S. Aulchenko,et al. BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .
[31] Jaana M. Hartikainen,et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.
[32] Deborah Hughes,et al. Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.
[33] J. Chang-Claude,et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes , 2005, Genetic epidemiology.
[34] I. Ellis,et al. Immunohistochemical analysis reveals a tumour suppressor‐like role for the transcription factor AP‐2 in invasive breast cancer , 1999, The Journal of pathology.
[35] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[36] Genica,et al. Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium , 2006 .